Beyond savings cards: pharmacy shopping, 30-day fills, manufacturer self-pay portals, and compounded fallback strategies.
The pricing landscape in July 2026
The cost of GLP-1 therapy in the United States spans an enormous range — from $99/mo for the cheapest compounded options to $1,349/mo for pharmacy-list brand Wegovy without insurance. Most patients land in the $119–$300/mo range with a combination of compounded programs and brand subscriptions.
What this means for you
NexLife is our editorial pick (94/100 on the v4.1 methodology). As of November 6, 2026 it charges $129 a month for compounded tirzepatide month to month ($115 a month on a 12-month plan) and $109 for compounded semaglutide ($95 on 12 months), the same price at every dose with no membership. Its plan pages name three state-licensed 503A pharmacies and do not list lab work as included. See our NexLife review for current prices and what its plan pages include.
Related cost guides
- The cheapest semaglutide options
- The cheapest tirzepatide options
- Medicare GLP-1 coverage (July 2026)
- Mounjaro savings card eligibility
- Using HSA/FSA for GLP-1